Literature DB >> 21866237

Off-pump coronary artery surgery in a patient with essential thrombocythaemia: two life-threatening complications in the same patient.

Kaan Kaya1, Raif Cavolli, Alpaslan Telli, Refik Tasoz.   

Abstract

Essential thrombocythaemia (ET) is a rare chronic myeloproliferative disease characterised by persistent thrombocytosis. Cerebral, myocardial and peripheral thrombosis are frequently seen complications, but bleeding and venous thrombosis are more rare. Here, a case of essential thrombocythaemia complicated by cerebral and myocardial thrombosis is presented. The patient's platelet count was 680×10(9)/litre on admission. Electrocardiogram showed a slight ST elevation in leads V1 to V4. A coronary angiography was performed and it revealed a severe stenosis of the left anterior descending artery. The patient had a successful off-pump coronary artery bypass grafting surgery. After the operation the platelet count was 390×10(9)/litre. The patient received hydroxyurea and aspirin treatment preoperatively and continued postoperatively. ET is a rare myeloproliferative disease; its complications are also rare, but the occurrence of two life-threatening complications in the same patient is rarer still. Further investigations are needed to determine the risk stratification for patients with ET undergoing cardiac surgery.

Entities:  

Year:  2009        PMID: 21866237      PMCID: PMC3027701          DOI: 10.1136/bcr.01.2009.1503

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  19 in total

1.  Essential thrombocytosis causing a massive myocardial infarction.

Authors:  Michel Haddad; John P Veinot; Roy G Masters; Paul J Hendry
Journal:  Cardiovasc Pathol       Date:  2003 Jul-Aug       Impact factor: 2.185

2.  Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.

Authors:  Peter J Campbell; Linda M Scott; Georgina Buck; Keith Wheatley; Clare L East; Joanne T Marsden; Audrey Duffy; Elaine M Boyd; Anthony J Bench; Mike A Scott; George S Vassiliou; Donald W Milligan; Steve R Smith; Wendy N Erber; David Bareford; Bridget S Wilkins; John T Reilly; Claire N Harrison; Anthony R Green
Journal:  Lancet       Date:  2005-12-03       Impact factor: 79.321

3.  Long-term outcome of 231 patients with essential thrombocythemia: prognostic factors for thrombosis, bleeding, myelofibrosis, and leukemia.

Authors:  Chor-Sang Chim; Yok-Lam Kwong; Albert Kwok-Wei Lie; Siu-Kwan Ma; Chi-Chung Chan; Lap-Gate Wong; Bonnie Chi San Kho; Harold-Kwok Lee; Joycelyn Pui-Yin Sim; Cheuk-Hung Chan; Joyce Chee-Wun Chan; Yiu-Ming Yeung; Martin Law; Raymond Liang
Journal:  Arch Intern Med       Date:  2005 Dec 12-26

4.  Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.

Authors:  Ross L Levine; Martha Wadleigh; Jan Cools; Benjamin L Ebert; Gerlinde Wernig; Brian J P Huntly; Titus J Boggon; Iwona Wlodarska; Jennifer J Clark; Sandra Moore; Jennifer Adelsperger; Sumin Koo; Jeffrey C Lee; Stacey Gabriel; Thomas Mercher; Alan D'Andrea; Stefan Fröhling; Konstanze Döhner; Peter Marynen; Peter Vandenberghe; Ruben A Mesa; Ayalew Tefferi; James D Griffin; Michael J Eck; William R Sellers; Matthew Meyerson; Todd R Golub; Stephanie J Lee; D Gary Gilliland
Journal:  Cancer Cell       Date:  2005-04       Impact factor: 31.743

5.  A gain-of-function mutation of JAK2 in myeloproliferative disorders.

Authors:  Robert Kralovics; Francesco Passamonti; Andreas S Buser; Soon-Siong Teo; Ralph Tiedt; Jakob R Passweg; Andre Tichelli; Mario Cazzola; Radek C Skoda
Journal:  N Engl J Med       Date:  2005-04-28       Impact factor: 91.245

Review 6.  New advances in the pathogenesis and therapy of essential thrombocythemia.

Authors:  Ross L Levine; Mark Heaney
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2008

Review 7.  The chronic myeloproliferative disorders: clonality and clinical heterogeneity.

Authors:  Jerry L Spivak
Journal:  Semin Hematol       Date:  2004-04       Impact factor: 3.851

8.  Comparison of early platelet activation in patients undergoing on-pump versus off-pump coronary artery bypass surgery.

Authors:  Andrea Ballotta; Hisham Z Saleh; Hisham W El Baghdady; Magdi Gomaa; Federica Belloli; Hassan Kandil; Yahia Balbaa; Fabrizio Bettini; Eduardo Bossone; Lorenzo Menicanti; Alessandro Frigiola; Carmen Bellucci; Rajendra H Mehta
Journal:  J Thorac Cardiovasc Surg       Date:  2007-07       Impact factor: 5.209

9.  Essential thrombocythemia in young individuals: frequency and risk factors for vascular events and evolution to myelofibrosis in 126 patients.

Authors:  A Alvarez-Larrán; F Cervantes; B Bellosillo; M Giralt; A Juliá; J C Hernández-Boluda; A Bosch; L Hernández-Nieto; V Clapés; C Burgaleta; C Salvador; E Arellano-Rodrigo; D Colomer; C Besses
Journal:  Leukemia       Date:  2007-04-12       Impact factor: 11.528

10.  Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors.

Authors:  Alexandra P Wolanskyj; Susan M Schwager; Rebecca F McClure; Dirk R Larson; Ayalew Tefferi
Journal:  Mayo Clin Proc       Date:  2006-02       Impact factor: 7.616

View more
  1 in total

1.  Off-pump myocardial revascularization in a high-risk patient with essential thrombocythemia.

Authors:  Ahmad K Darwazah; Hamad Madi; Rami Zagha; Yahia Hawash
Journal:  Tex Heart Inst J       Date:  2014-10-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.